메뉴 건너뛰기




Volumn 158, Issue 2, 2000, Pages 119-124

Improvement of idarubicin induced antitumor activity and bone marrow suppression by theanine, a component of tea

Author keywords

Adverse reaction; Biochemical modulation; Bone marrow suppression; Idarubicin; Theanine

Indexed keywords

IDAMYCIN R; IDARUBICIN; NATURAL PRODUCT; THEANINE; UNCLASSIFIED DRUG;

EID: 0034308198     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3835(00)00491-2     Document Type: Article
Times cited : (30)

References (20)
  • 1
    • 0032238156 scopus 로고    scopus 로고
    • Targeting of anti-cancer drugs with nano-sized carrier system
    • M. Yokoyama, T. Okano, Targeting of anti-cancer drugs with nano-sized carrier system, Jpn. J. Clin. Med. 56 (1998) 3227-3234.
    • (1998) Jpn. J. Clin. Med. , vol.56 , pp. 3227-3234
    • Yokoyama, M.1    Okano, T.2
  • 2
    • 0031034757 scopus 로고    scopus 로고
    • Effects of administered route on tissue distribution and antitumor activity of polyethyleneglycol-coated liposomes containing adriamycin
    • Y. Sadzuka, S. Nakai, A. Miyagishima, Y. Nozawa, S. Hirota, Effects of administered route on tissue distribution and antitumor activity of polyethyleneglycol-coated liposomes containing adriamycin, Cancer Lett. 111 (1997) 77-86.
    • (1997) Cancer Lett. , vol.111 , pp. 77-86
    • Sadzuka, Y.1    Nakai, S.2    Miyagishima, A.3    Nozawa, Y.4    Hirota, S.5
  • 3
    • 0025731906 scopus 로고
    • Liposomes containing synthetic lipid derivatives of polyethylene glycol show prolonged circulation half-lives in vivo
    • T.M. Allen, C. Hansen, F. Martin, C. Redemann, A. Yau-Young, Liposomes containing synthetic lipid derivatives of polyethylene glycol show prolonged circulation half-lives in vivo, Biochim. Biophys. Acta 1066 (1991) 29-36.
    • (1991) Biochim. Biophys. Acta , vol.1066 , pp. 29-36
    • Allen, T.M.1    Hansen, C.2    Martin, F.3    Redemann, C.4    Yau-Young, A.5
  • 4
    • 0032523735 scopus 로고    scopus 로고
    • Effect of liposomalization on the antitumor activity, side effect and tissue distribution of CPT-11
    • Y. Sadzuka, S. Hirotsu, S. Hirota, Effect of liposomalization on the antitumor activity, side effect and tissue distribution of CPT-11, Cancer Lett. 127 (1998) 99-106.
    • (1998) Cancer Lett. , vol.127 , pp. 99-106
    • Sadzuka, Y.1    Hirotsu, S.2    Hirota, S.3
  • 5
    • 0033065077 scopus 로고    scopus 로고
    • Effective irinotecan (CPT-11)-containing liposomes: Intraliposomal conversion to the active metabolite SN-38
    • Y. Sadzuka, S. Hirotsu, S. Hirota, Effective irinotecan (CPT-11)-containing liposomes: intraliposomal conversion to the active metabolite SN-38, Jpn. J. Cancer Res. 90 (1999) 226-232.
    • (1999) Jpn. J. Cancer Res. , vol.90 , pp. 226-232
    • Sadzuka, Y.1    Hirotsu, S.2    Hirota, S.3
  • 6
    • 0027453162 scopus 로고
    • Caffeine modulates the antitumor activity and toxic side effects of adriamycin
    • Y. Sadzuka, E. Mochizuki, Y. Takino, Caffeine modulates the antitumor activity and toxic side effects of adriamycin, Jpn. J. Cancer. Res. 84 (1993) 348-353.
    • (1993) Jpn. J. Cancer. Res. , vol.84 , pp. 348-353
    • Sadzuka, Y.1    Mochizuki, E.2    Takino, Y.3
  • 7
    • 0028888231 scopus 로고
    • Mechanism of caffeine modulation of the antitumor activity of adriamycin
    • Y. Sadzuka, E. Mochizuki, Y. Takino, Mechanism of caffeine modulation of the antitumor activity of adriamycin, Toxicol. Lett. 75 (1995) 39-49.
    • (1995) Toxicol. Lett. , vol.75 , pp. 39-49
    • Sadzuka, Y.1    Mochizuki, E.2    Takino, Y.3
  • 8
    • 0029022685 scopus 로고
    • Effects of methylxanthine derivatives on adriamycin concentration and antitumor activity
    • Y. Sadzuka, A. Iwazaki, A. Miyagishima, Y. Nozawa, S. Hirota, Effects of methylxanthine derivatives on adriamycin concentration and antitumor activity, Jpn. J. Cancer. Res. 86 (1995) 594-599.
    • (1995) Jpn. J. Cancer. Res. , vol.86 , pp. 594-599
    • Sadzuka, Y.1    Iwazaki, A.2    Miyagishima, A.3    Nozawa, Y.4    Hirota, S.5
  • 9
    • 0031952418 scopus 로고    scopus 로고
    • 1-Methyl-3-propyl-7-butylxanthine, a novel biochemical modulator, enhances therapeutic efficacy of adriamycin
    • Y. Sadzuka, A. Iwazaki, T. Sugiyama, H. Sawanishi, K. Miyamoto, 1-Methyl-3-propyl-7-butylxanthine, a novel biochemical modulator, enhances therapeutic efficacy of adriamycin, Jpn. J. Cancer. Res. 89 (1998) 228-233.
    • (1998) Jpn. J. Cancer. Res. , vol.89 , pp. 228-233
    • Sadzuka, Y.1    Iwazaki, A.2    Sugiyama, T.3    Sawanishi, H.4    Miyamoto, K.5
  • 10
    • 0030565012 scopus 로고    scopus 로고
    • The effects of theanine, as a novel biochemical modulator, on the antitumor activity of adriamycin
    • Y. Sadzuka, T. Sugiyama, A. Miyagishima, Y. Nozawa, S. Hirota, The effects of theanine, as a novel biochemical modulator, on the antitumor activity of adriamycin, Cancer Lett. 105 (1996) 203-209.
    • (1996) Cancer Lett. , vol.105 , pp. 203-209
    • Sadzuka, Y.1    Sugiyama, T.2    Miyagishima, A.3    Nozawa, Y.4    Hirota, S.5
  • 11
    • 0031907021 scopus 로고    scopus 로고
    • Modulation of cancer chemotherapy by green tea
    • Y. Sadzuka, T. Sugiyama, S. Hirota, Modulation of cancer chemotherapy by green tea, Clin. Cancer Res. 4 (1998) 153-156.
    • (1998) Clin. Cancer Res. , vol.4 , pp. 153-156
    • Sadzuka, Y.1    Sugiyama, T.2    Hirota, S.3
  • 12
    • 0032433184 scopus 로고    scopus 로고
    • Enhancing effects of green tea components on the antitumor activity of adriamycin against M5076 ovarian sarcoma
    • T. Sugiyama, Y. Sadzuka, Enhancing effects of green tea components on the antitumor activity of adriamycin against M5076 ovarian sarcoma, Cancer Lett. 133 (1998) 19-26.
    • (1998) Cancer Lett. , vol.133 , pp. 19-26
    • Sugiyama, T.1    Sadzuka, Y.2
  • 13
    • 0033009624 scopus 로고    scopus 로고
    • Combination of theanine with doxorubicin inhibits hepatic metastasis of M5076 ovarian sarcoma
    • T. Sugiyama, Y. Sadzuka, Combination of theanine with doxorubicin inhibits hepatic metastasis of M5076 ovarian sarcoma, Clin. Cancer Res. 5 (1999) 413-416.
    • (1999) Clin. Cancer Res. , vol.5 , pp. 413-416
    • Sugiyama, T.1    Sadzuka, Y.2
  • 14
    • 0027195064 scopus 로고
    • Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia
    • T. Tsuruo, T. Oh-hara, Y. Sudo, M. Naito, Antitumor activity of idarubicin, a derivative of daunorubicin, against drug sensitive and resistant P388 leukemia, Anticancer Res. 13 (1993) 357-362.
    • (1993) Anticancer Res. , vol.13 , pp. 357-362
    • Tsuruo, T.1    Oh-hara, T.2    Sudo, Y.3    Naito, M.4
  • 15
    • 0027258426 scopus 로고
    • Early phase II study of idarubicin, a new anthracycline anticancer drug, in acute leukemia
    • M. Ogawa, T. Masaoka, K. Yamada, K. Kimura, Early phase II study of idarubicin, a new anthracycline anticancer drug, in acute leukemia, Jpn. J. Cancer Chemother. 20 (1993) 897-906.
    • (1993) Jpn. J. Cancer Chemother. , vol.20 , pp. 897-906
    • Ogawa, M.1    Masaoka, T.2    Yamada, K.3    Kimura, K.4
  • 16
    • 0017075224 scopus 로고
    • Adriamycin: Amelioration of toxicity by α-tocopherol
    • C.E. Myers, W.P. McGuire, R.C. Young, Adriamycin: amelioration of toxicity by α-tocopherol, Cancer Treat. Rep. 60 (1976) 961-962.
    • (1976) Cancer Treat. Rep. , vol.60 , pp. 961-962
    • Myers, C.E.1    McGuire, W.P.2    Young, R.C.3
  • 17
    • 0024842717 scopus 로고
    • Effect of adriamycin on the activities of Superoxide dismutase, glutathione peroxidase and catalase in tissues of mice
    • Y. Sadzuka, H. Tanizawa, Y. Takino, Effect of adriamycin on the activities of Superoxide dismutase, glutathione peroxidase and catalase in tissues of mice, Jpn. J. Cancer Res. 80 (1989) 89-94.
    • (1989) Jpn. J. Cancer Res. , vol.80 , pp. 89-94
    • Sadzuka, Y.1    Tanizawa, H.2    Takino, Y.3
  • 18
    • 0030070072 scopus 로고    scopus 로고
    • Transport mechanism of anthracycline derivatives in human leukemia cell lines: Uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells
    • K. Nagasawa, T. Natazuka, K. Chihara, F. Kitazawa, A. Tsumura, K. Takara, M. Nomiyama, N. Ohnishi, T. Yokoyama, Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells, Cancer Chemother. Pharmacol. 37 (1996) 297-304.
    • (1996) Cancer Chemother. Pharmacol. , vol.37 , pp. 297-304
    • Nagasawa, K.1    Natazuka, T.2    Chihara, K.3    Kitazawa, F.4    Tsumura, A.5    Takara, K.6    Nomiyama, M.7    Ohnishi, N.8    Yokoyama, T.9
  • 19
    • 0030779932 scopus 로고    scopus 로고
    • Transport mechanism of idarubicin, an anthracycline derivatives, in human leukemia HL60 cells and mononuclear cells, and comparison with those of its analogs
    • K. Nagasawa, N. Ohnishi, T. Yokoyama, Transport mechanism of idarubicin, an anthracycline derivatives, in human leukemia HL60 cells and mononuclear cells, and comparison with those of its analogs, Jpn. J. Cancer Res. 88 (1997) 750-759.
    • (1997) Jpn. J. Cancer Res. , vol.88 , pp. 750-759
    • Nagasawa, K.1    Ohnishi, N.2    Yokoyama, T.3
  • 20
    • 0031819446 scopus 로고    scopus 로고
    • Possibility of contribution of nucleoside transport system to pirarubicin uptake by HL60 cells but not mononuclear cells
    • K. Nagasawa, N. Ohnishi, T. Yokoyama, Possibility of contribution of nucleoside transport system to pirarubicin uptake by HL60 cells but not mononuclear cells, Jpn. J. Cancer Res. 89 (1998) 673-680.
    • (1998) Jpn. J. Cancer Res. , vol.89 , pp. 673-680
    • Nagasawa, K.1    Ohnishi, N.2    Yokoyama, T.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.